Bong Dug Koh is an Angel Investor with a keen interest in the biopharma sector. See sector focus and contact routes.
Bong Dug Koh is an Angel Investor with a keen interest in the biopharma sector. As an individual investor, Koh is closely associated with Endpoints News, a prominent publication dedicated to covering the intricacies of the biopharmaceutical industry. This association highlights Koh's engagement with the latest developments in biotech and pharmaceuticals. Endpoints News provides comprehensive coverage of critical industry events, including significant deals, financing rounds, and regulatory milestones such as FDA approvals. Koh's involvement as an Angel Investor, particularly with a focus on an information source like Endpoints News, underscores a commitment to understanding and potentially supporting innovation within the dynamic biopharma landscape.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Los Angeles when building a target list.
Investors like Bong Dug Koh · Full investor directory · Investor access · Company funding database